Recovery Legal Care Clinical Trial
Launched by UNIVERSITY OF CHICAGO · Sep 26, 2024
Trial Information
Current as of November 01, 2025
Recruiting
Keywords
ClinConnect Summary
The Recovery Legal Care Clinical Trial is studying a new program that combines legal support with help for people who have suffered violent injuries, like gunshot wounds. This program is designed to not only assist individuals with their immediate needs after an injury but also address bigger issues that can lead to violence, such as economic struggles and systemic racism. The goal is to see if this partnership can improve the lives of participants by reducing stress, improving legal situations, and enhancing overall health and well-being.
To participate in this study, individuals must be between 14 and 64 years old and have received treatment for a violent injury at the University of Chicago Trauma Center. Participants will receive help from legal experts alongside the medical care they already receive. Importantly, the trial is focused on including a diverse group of people, particularly those from low-income backgrounds and underrepresented communities. If you or someone you know qualifies, participating could lead to valuable support and insights into how to reduce violence and improve health outcomes in our communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Treatment for a violent injury at the University of Chicago Trauma Center
- • Ages 14-64 years
- • Able to provide informed consent (18 years and older) or assent (14-17 years)
- • Inclusion of women and minorities: This research proposal includes women and ethnic minorities. Patient participants will be primarily non-Hispanic Black or Hispanic race and ethnicity. The study expects participants to be proportional to the population-wide estimates for the South Side community. The majority will be low-income with variable functional health literacy. These characteristics are representative of the target population and describe the population most likely to benefit from the proposed study. Youth stakeholder participants will be multi-ethnic and racially diverse.
- • Inclusion of children: This study will include children ages 14-17 years old, based on Illinois state labor laws for child employment, as well as the ages of youth who are primarily treated for penetrating injury at the UCMC trauma center. This age is also a pragmatic cutoff for children providing meaningful input on community and healthcare solutions to violence.
- Exclusion Criteria:
- • Diagnosis of severe mental illness (i.e., psychotic disorder, schizophrenia, suicidality)
- • Unable to provide informed consent due to mental status
- • Prior receipt of legal services at UCMC within the past year
- • Currently imprisoned or incarcerated
- • Residing at an Indiana address.
About University Of Chicago
The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
TANYA L ZAKRISON, MD, MPH
Principal Investigator
University of Chicago
ELIZABETH L TUNG, MD, MS
Principal Investigator
University of Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported